PT-141 (bremelanotide) PT-141
Melanocortin receptor agonist; approved prescription medicine in the United States since 2019.
US only
Monograph plannedAll content is for general information only — not medical advice, not a dosing or usage recommendation, and not a claim of efficacy. Many substances are not approved as medicines or are prescription-only; whether possession and use are legal depends on the law of your country of residence and is your own responsibility. myPeptides does not sell or supply any substances — it is an information and organization tool. For health questions, consult a licensed physician or pharmacist.
Every peptide covered here, with its mechanism class, legal status and WADA status. This is a status register, not a shop: no suppliers, no doses, no efficacy claims.
3 of 73
Melanocortin-1 receptor agonist; approved prescription medicine in the US and the EU.
Approved for a rare photodermatosis only
MonographNon-selective melanocortin receptor agonist; never submitted for approval in any market.
MonographMelanocortin receptor agonist; approved prescription medicine in the United States since 2019.
US only
Monograph plannedTrack doses, plans and progress on your phone — end-to-end encrypted.
This article is for informational purposes only and does not replace medical advice. myPeptides gives no dosing recommendations.